This groundbreaking legislation will create facilities that will attract the world’s best researchers to partner with the state’s renowned life sciences industry to unravel the mysteries of stem cells in order to develop cures for now-hopeless degenerative and neurological disorders.
The Stem Cell and Biomedical Research Facilities Initiative includes:
- $150 million for the Stem Cell Institute of New Jersey in New Brunswick
- $50 million for stem cell facilities at the New Jersey Institute of Technology in Newark
- $50 million for biomedical research facilities located at Rutgers-Camden
- $10 million for blood collection facilities operated by Elie Katz Umbilical Cord Blood Program
- $10 million for the Garden State Cancer Center
The Stem Cell Institute of NJ will be built in downtown New Brunswick adjacent to Robert Wood Johnson University Hospital and across the street from the Cancer Institute of New Jersey.
The Institute will have facilities for basic research as well as outpatient treatment. It will include an access corridor to RWJU Hospital to facilitate patient treatment as well as for doctors to move easily from their research lab to their patient’s bedside.
All of the areas of research related to stem cell biology and treatment must be carried out in sophisticated laboratories with costly, state-of-the-art equipment. A core facility will increase efficiency and offer the possibility of sharing high-level technical equipment, initiating joint research and training, and reducing duplication of effort.
The Search for a Scientific Director is underway. Dr. Wise Young, Chair of the Department of Cell Biology & Neuroscience at Rutgers University, chairs the Search Committee, which includes members from both Rutgers and UMDNJ.
View the designs for the Stem Cell Institute of New Jersey
